HS2ST1 and cancer: Notably, HS2ST1 emerged as a novel biomarker, potentially promoting cancer stem cell-like properties via heparan sulfate-mediated enhancement of Wnt/β-catenin signaling, highlighting its dual value as both a prognostic indicator and a therapeutic target.